Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Study to Evaluate the Effectiveness of Furosemide Plus Sodium Chloride to Prevent Contrast-Induced Nephropathy
2008-001200-23Phase 2Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of furosemide in contrast-induced nephropathy (CIN) and chronic kidney disease (CKD), sponsored by Centro Cardiologico Monzino. Primary endpoint: Incidence of contrast-induced nephropathy. Started May 2008; status: completed.
02
Drugs
furosemide
03
Conditions
contrast-induced nephropathy (CIN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-001200-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001200-23.